aecopd的两种治疗方法药物经济学的研究.doc
约9页DOC格式手机打开展开
aecopd的两种治疗方法药物经济学的研究,aecopd的两种治疗方法药物经济学的研究摘要：目的 研究两种治疗方法治疗慢性阻塞性肺疾病伴急性加重期（aecopd）的药物经济学效果。方法 采用回顾性研究方法，将102例aecopd患者按照治疗方法中使用的抗菌药物不同分为美洛西林舒巴坦钠组(a组)和头孢米诺钠组(b组)，住院天数为7~14天，分别观察2组治疗后的疗效...
内容介绍
此文档由会员 woyaoshou 发布
AECOPD的两种治疗方法药物经济学的研究
摘要：目的 研究两种治疗方法治疗慢性阻塞性肺疾病伴急性加重期（AECOPD）的药物经济学效果。方法 采用回顾性研究方法，将102例AECOPD患者按照治疗方法中使用的抗菌药物不同分为美洛西林舒巴坦钠组(A组)和头孢米诺钠组(B组)，住院天数为7~14天，分别观察2组治疗后的疗效和不良反应发生率并以其评估治疗的效果，然后运用药物经济学评价方法中的成本-效果分析方法、敏感度分析方法及DDDs进行分析。结果 A组和B组临床总有效率分别为93.55%、95.00%(P>0.05)，不良反应发生率分别为3.23%、2.50%；平均住院时间分别为(9.19±2.17)天和(8.90±1.98)天，譆@杀痉直鹞�(7695.18±2993.02)元、(9648.49±2631.41)元，统计学分析两组有显著性差异（P0.05)。结论 治疗AECOPD，美洛西林舒巴坦钠治疗方法较头孢米诺钠治疗方法经济、有效、合理。
关键词：慢性阻塞性肺疾病伴急性加重期；治疗方法；成本-效果分析；敏感度分析；
DDDs
Abstract: Objective To research chronic obstructive pulmonary disease with acute exacerbation ( AECOPD) of two antibaccterial drug treatments of pharmacoeconomic effect. Methods by a retrospective exploration, so medical records were divided into Mezlocillin sodium/Sulbactam sodium (A)group and Cefninox sodium (B)group as different treatment methods, the length of hospital stay was 7~14 days, then observed 2 groups of adverse reaction and curative effect after treatment, and eva luated the effect of treatment with those, the last cost-effectiveness analysis(CEA),sensitivity analysis and frequency of medication DDDs were performed. Results The clinical total effective rates in group A and group B were 93.55% and 95.00%,the incidence of adverse reaction were 3.23%, 2.50%,Mean length of hospital stay were (9.19±2.17)days and (8.90±1.98)days, and the total costs were (7695.18±2993.02) Yuan and (9648.49±2631.41)Yuan, statistical analysis of the two groups had significant difference (P<0.05);The cost-effectiveness ratio of Mezlocillin sodium/Sulbactam sodium (A)group is lower than that of Cefninox (B)group, the sensitivity analysis results are consistent with results of parameter change.In addition, DDDsA
Keywords:AECOPD; Methods of treatment; Cost-effectiveness analysis ; Sensitivity analysis ;DDDs
摘要：目的 研究两种治疗方法治疗慢性阻塞性肺疾病伴急性加重期（AECOPD）的药物经济学效果。方法 采用回顾性研究方法，将102例AECOPD患者按照治疗方法中使用的抗菌药物不同分为美洛西林舒巴坦钠组(A组)和头孢米诺钠组(B组)，住院天数为7~14天，分别观察2组治疗后的疗效和不良反应发生率并以其评估治疗的效果，然后运用药物经济学评价方法中的成本-效果分析方法、敏感度分析方法及DDDs进行分析。结果 A组和B组临床总有效率分别为93.55%、95.00%(P>0.05)，不良反应发生率分别为3.23%、2.50%；平均住院时间分别为(9.19±2.17)天和(8.90±1.98)天，譆@杀痉直鹞�(7695.18±2993.02)元、(9648.49±2631.41)元，统计学分析两组有显著性差异（P0.05)。结论 治疗AECOPD，美洛西林舒巴坦钠治疗方法较头孢米诺钠治疗方法经济、有效、合理。
关键词：慢性阻塞性肺疾病伴急性加重期；治疗方法；成本-效果分析；敏感度分析；
DDDs
Abstract: Objective To research chronic obstructive pulmonary disease with acute exacerbation ( AECOPD) of two antibaccterial drug treatments of pharmacoeconomic effect. Methods by a retrospective exploration, so medical records were divided into Mezlocillin sodium/Sulbactam sodium (A)group and Cefninox sodium (B)group as different treatment methods, the length of hospital stay was 7~14 days, then observed 2 groups of adverse reaction and curative effect after treatment, and eva luated the effect of treatment with those, the last cost-effectiveness analysis(CEA),sensitivity analysis and frequency of medication DDDs were performed. Results The clinical total effective rates in group A and group B were 93.55% and 95.00%,the incidence of adverse reaction were 3.23%, 2.50%,Mean length of hospital stay were (9.19±2.17)days and (8.90±1.98)days, and the total costs were (7695.18±2993.02) Yuan and (9648.49±2631.41)Yuan, statistical analysis of the two groups had significant difference (P<0.05);The cost-effectiveness ratio of Mezlocillin sodium/Sulbactam sodium (A)group is lower than that of Cefninox (B)group, the sensitivity analysis results are consistent with results of parameter change.In addition, DDDsA
Keywords:AECOPD; Methods of treatment; Cost-effectiveness analysis ; Sensitivity analysis ;DDDs
